This resolution designates May 2026 as ALS Awareness Month to recognize the impact of amyotrophic lateral sclerosis and affirm dedication to supporting those affected by the disease.
Christopher Coons
Senator
DE
This resolution officially designates May 2026 as ALS Awareness Month. It recognizes the devastating impact of amyotrophic lateral sclerosis (ALS) and affirms the Senate's dedication to improving access to treatments and supports for those affected. The bill also commits to supporting research to find causes, risk factors, and a cure for ALS.
Senate Designates May 2026 as ALS Awareness Month to Speed Up Support and Research
This resolution officially marks May 2026 as ALS Awareness Month, but it does a lot more than just pick a date on the calendar. It serves as a formal acknowledgment of the brutal reality of Amyotrophic Lateral Sclerosis—a disease that currently has no cure and often leaves patients with a life expectancy of just two to five years after diagnosis. By putting these facts into the record, the Senate is setting a baseline for what needs to change, from the average 12-month wait for a diagnosis to the fact that 15 people are diagnosed with the condition every single day.
The Veteran Connection and Caregiver Costs
One of the most striking details in this resolution is the specific mention of our military veterans, who are statistically more likely to develop ALS than the general population. For families in the 25-45 age bracket who might be caring for an aging parent or a spouse, the resolution highlights the massive financial and emotional toll involved. It acknowledges that the cost of medical equipment, home care, and specialized services can be staggering as the disease progresses toward total paralysis. By recognizing these burdens, the resolution aims to push for better access to high-quality services and supports as soon as a diagnosis is made, rather than months down the line.
A Roadmap for Support
The resolution isn't just about looking back at the statistics; it’s a commitment to several specific goals. It affirms the Senate’s dedication to empowering patients to keep their independence for as long as possible and finding the genetic or environmental triggers that cause 90 percent of cases to appear seemingly out of nowhere. For the researchers in labs and the family members acting as full-time nurses, this is a formal nod to their work. While it doesn't immediately hand out new funding, it creates a legislative framework that prioritizes reducing the physical and emotional weight of the disease for the tens of thousands of Americans living with it today.